))
Talking the Cure: Discussing COVID-19’s impact on FDA’s inspection program and next steps after the pandemic
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on September 25, 2024 14:55 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 290829676 series 2916794
Konten disediakan oleh Hogan Lovells. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Hogan Lovells atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
In this episode, Phil Katz and Jim Johnson continue their conversation about the impact of COVID-19 on FDA’s drug inspection program and the steps companies should take now and in preparation for when the pandemic is coming to an end. For all updates around COVID-19, visit our COVID-19 hub. You can find additional thought leadership and information regarding Medical Devices and Technology Regulatory on HL Engage. If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.
…
continue reading
52 episode
Bagikan
